The effect of vitamin D on epilepsy

The Effect of Vitamin D on the Frequency of Epileptic Seizures: A Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial - The effect of vitamin D on epilepsy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2012-001826-84-HU

Enrollment

100

Registered

2012-08-10

Start date

2012-12-13

Completion date

Unknown

Last updated

2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

Trade Name: Vigantol Oil Pharmaceutical Form: Oral drops, solution Pharmaceutical form of the placebo: Oral drops Route of administration of the placebo: Oral use

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: pharmacoresistancy age: > 18 years serum level of 25(OH)D =65 years) yes F.1.3.1 Number of subjects for this age range 10

Exclusion criteria

Exclusion criteria: presence of psychogenic seizures pregnancy, lactation impaired kidney function history of sarcoidosis

Design outcomes

Primary

Measure	Time frame
Main Objective: To examine the effect of vitamin D3 in epilepsy patients;Secondary Objective: To examine the effect of vitamin D3 on psychometric parameters;Primary end point(s): change in seizure frequency;Timepoint(s) of evaluation of this end point: Time intervals for the first and second 4 months	—

Secondary

Measure	Time frame
Secondary end point(s): change in the psycometric parameters;Timepoint(s) of evaluation of this end point: Time intervals for the first and second 4 months	—

Countries

Hungary

Contacts

Public ContactUniversity of Pécs

University of Pécs

jozsef.janszky@gmail.com3672535-900

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026